If the syringe fills with blood, remove the needle and start again at site a few centimetres further down your leg
Cycle Guidelines Common NAD+ Cycle Reference Approach Standard SubQ Duration 4-8 weeks Review point Week 4 Best for General research-context cellular-energy planning Approach Extended SubQ + oral bridge Duration 8-12 weeks SubQ, then 4 weeks oral NMN/NR Review point End of injectable phase Best for Layered approach combining injection and oral precursors Approach IV maintenance Duration Weekly or bi-weekly, ongoing Review point Every 4-8 weeks Best for Clinic-supervised research planning Approach IV loading + maintenance Duration 3-5 daily IV sessions, then weekly/monthly Review point After loading phase Best for Intensive clinic protocol Unlike receptor-based peptides, NAD+ is a coenzyme
Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
[5] The primary contraindication for hydroxocobalamin injection is a known hypersensitivity to hydroxocobalamin, cobalt, or any component of the formulation
So, does BPC-157 help with weight loss
